Notice of Extraordinary General Meeting of Brain+ A/S

Notice is hereby given for an Extraordinary General Meeting in Brain+ A/S, CVR. No. 36439440 (“Company”) to be held Thursday, 13 April 2023 at 3 PM (15:00 CEST).

The Extraordinary General Meeting will be held at the Company’s registered address at: Købmagergade 53, 3 1150 København K, Denmark.

The shareholders of Brain+ A/S are hereby invited to attend an Extraordinary General Meeting on Thursday 13th April 2023 at 15:00 (CEST). The Extraordinary General Meeting will take place at Købmagergade 53, 3. 1150 Copenhagen as a physical event.

Please find the invitation and appendices attached.

For additional information regarding registration, proxy and postal votes please visit www.brain-plus.com/investor

Contact Information

CEO, Kim Baden-Kristensen + 45 31393317, E-mail: kim@brain-plus.com, Brain+ A/S, Købmagergade 53, 3.

Certified Advisor: Keswick Global AG, + 43 1 740 408 045, E-mail: info@keswickglobal.com

The mission of Brain+ is to protect people’s independence and quality of life by making effective treatments for cognitive decline in dementia accessible to everyone as digital therapeutics.